The project, in which VisMederi Research is a partner, is aimed at developing diagnostic and theranostic targeting based on nanosystems and/or engineered lymphocytes for the early detection and treatment of melanoma, and multiple sclerosis. With its participation in the INSIDE project, VisMederi Research aims at entering the wider market of contract research in the pharmaceutical sector, linked to the development of drugs in a broad sense, broadening the scope beyond the vaccines segment.
